Effect of a New Formulation of Vitamin B12 on Physical and Mental
NCT ID: NCT06639789
Last Updated: 2024-10-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
18 participants
INTERVENTIONAL
2024-07-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oral Vitamin B12 Supplementation and Cognitive Performance in Elderly People
NCT00111267
Effect of Methylcobalamin and Cyanocobalamin Consumption on Vitamin B12 Nutritional Status
NCT05785585
Oral/Intramuscular B12 to Treat Cobalamin Deficiency
NCT01476007
Vitamin B12 Biomarker Responses to Supplementation
NCT04731948
Assessing the Efficacy of Different Carrier Systems in Oral Vitamin B12 Supplementation
NCT06376591
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All participants were informed about the procedures and provided signed informed consent. The study was conducted in accordance with the guidelines of the Declaration of Helsinki Declaration for Research Involving Human Subjects and the protocol was approved by the Institutional Review/Ethics Committee of the Catholic University of Murcia (Code: CE052416).
Study design
Randomized, double-blind, placebo-controlled, crossover clinical trial with 2 study groups (vitamin B12 and placebo). Cyclists were instructed to take the supplement (vitamin B12 or placebo) with breakfast on the three days before the tests and 3h before the test day, and to continue with their usual diet and training programme. Subjects in both groups were instructed not to consume vitamin B12-rich foods for 7 days before and during the study. Between each intervention (B12 and Placebo) there was a 7-day washout period.
Procedures
Participants visited the laboratory on three occasions. Visit 1 consisted of a medical examination and a blood draw to determine health status. At visits 2 and 3, a 24-hour diet reminder and a Wingate test, mental fatigue test and venous blood draw were performed. The sports nutritionist prescribed a standardized breakfast before each testing session (visits 2 and 3).
Pre- and post-evaluation test
Visit 1:
Health status blood test: A general blood test will be performed both pre- and post-supplementation. The blood will be drawn through a vein (fasting).
Medical examination: A medical history of family and personal history, an electrocardiogram (ECG) at rest and a medical examination (auscultation, blood pressure, etc.) will be carried out to certify that the person is healthy and does not present a risk to participate in the study (Fasting).
Body composition by absorptiometric densitometry (DXA): A body composition test will be performed using the double energy absorptiometric densitometry technique (X-rays), with the aim of determining parameters of fat mass, fat-free mass and fat percentage. In addition, anthropometry will also be used to determine changes in body composition (fat and muscle mass) (Fasting).
Visits 2 and 3:
Anaerobic power and mechanical power output: After a standardised breakfast, a Wingate test was performed on a cycle ergometer. The Wingate test (WAnT) consisted of a 30 s sprint on a cycle ergometer (Monark Ergomedic 894E Peak Bike, Vansbro, Sweden). Breaking strength was held constant at 7.5% of each individual's body mass. All participants were verbally encouraged to pedal as fast as possible throughout the sprint.
Mental fatigue test: All participants will be tested for the evaluation of reaction time to a sequence of lights set by the investigator before and after the performance test.
Biochemical markers: A venous blood draw will be performed by medical personnel before and after the performance test, in which vitamin B12, creatine kinase and lactate dehydrogenase levels will be analyzed.
All data of the subjects who participated in the study were stored in a computer system with a security key. In addition, some of the data was also recorded on paper and kept under lock and key, accessible only to the researchers of this project.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitamin B12 (B12)
Subjects in this group will intake 1 mg/day of vitamin B12 three days before the tests.
Vitamin B12 (B12)
The new formulation of vitamin B12 will be ingested 3 days before and on the day of testing (3 hours before).
PLACEBO (PLA)
Subjects in this group will intake 200 mg/day of microcrystalline cellulose three days before the tests.
PLACEBO (PLA)
The placebo will be ingested 3 days before and the same day of the tests (3 hours before).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin B12 (B12)
The new formulation of vitamin B12 will be ingested 3 days before and on the day of testing (3 hours before).
PLACEBO (PLA)
The placebo will be ingested 3 days before and the same day of the tests (3 hours before).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cycling between 6-15 hours of training per week.
* BMI between 18-25 kg/m2.
Exclusion Criteria
* Persons suffering from a metabolic, cardiorespiratory or digestive pathology or anomaly.
digestive system.
* People who have suffered an injury in the last 6 months that limits the performance of the study tests. of the study tests.
* People taking supplements or medication in the 2 weeks before the start of the study.
18 Years
45 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Católica San Antonio de Murcia
OTHER
Francisco Javier Martínez Noguera
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Francisco Javier Martínez Noguera
PhD (Head of the nutrition area of the Research Center for High Performance Sport)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Francisco Javier J Martínez Noguera
Role: STUDY_CHAIR
Research Center for High Performance Sport. Catholic University of Murcia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Center for High Performance Sport. Catholic University of Murcia
La Ñora, Murcia, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CE052416
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.